+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Chronic Pain Therapy Solutions for Joints Market by Therapy Type, Administration Route, Product Type, Distribution Channel, End User, Pathology, Mechanism of Action, Technology - Global Forecast 2025-2030- Product Image
Chronic Pain Therapy Solutions for Joints Market by Therapy Type, Administration Route, Product Type, Distribution Channel, End User, Pathology, Mechanism of Action, Technology - Global Forecast 2025-2030- Product Image
New

Chronic Pain Therapy Solutions for Joints Market by Therapy Type, Administration Route, Product Type, Distribution Channel, End User, Pathology, Mechanism of Action, Technology - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6142643
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Joint pain remains one of the most pervasive and debilitating chronic conditions globally, impacting patient quality of life and placing significant strain on healthcare systems. This introduction establishes the critical need for advanced therapeutic solutions that address both the physiological and psychosocial dimensions of chronic joint discomfort. By framing the complexity of pain modulation, tissue regeneration, and patient adherence, the study sets the stage for an insightful exploration of emerging interventions and clinical pathways.

Building on this foundation, the narrative highlights how evolving patient expectations and regulatory landscapes are driving a paradigm shift toward more personalized and multidisciplinary approaches. Integration of technological innovations with evidence-based medicine not only enhances symptom management but also fosters sustainable outcomes. By examining key drivers such as demographic changes, healthcare policy reforms, and technological breakthroughs, this overview underscores the urgency of developing novel modalities that can adapt to the nuanced demands of modern therapeutic practice.

In-Depth Exploration of Transformative Shifts in Joint Pain Treatment Paradigms Driven by Technological Advances and Patient-Centric Care Models

Recent years have witnessed profound shifts in the joint pain therapy landscape, propelled by breakthroughs in digital health platforms, biologic agents, and precision medicine. Telemedicine consultations and virtual reality rehabilitation programs have emerged as powerful tools for remote patient engagement, enabling continuous monitoring of pain metrics and functional outcomes. Meanwhile, the rise of wearables equipped with biosensors facilitates real-time feedback loops that inform personalized treatment adjustments, enhancing both safety and efficacy.

Concurrently, collaboration between device manufacturers, pharmaceutical companies, and academic research centers has accelerated the translation of laboratory discoveries into clinical applications. From next-generation neuromodulation devices to novel injectable formulations, these cross-sector alliances are redefining standard-of-care protocols. As regulatory bodies increasingly prioritize value-based reimbursement structures, the focus has shifted toward interventions that demonstrate clear improvements in patient functionality and cost-efficiency, further fueling transformative innovation across the therapy continuum.

Comprehensive Analysis of the Cumulative Impact of United States Tariffs Implemented in 2025 on Joint Pain Therapy Supply Chains and Costs

The imposition of new tariff measures by the United States in 2025 has introduced notable complexities into the supply chain for joint pain therapeutic solutions. Import duties on critical active pharmaceutical ingredients and specialized device components have triggered cost adjustments across multiple tiers of the distribution network. In response, manufacturers are reassessing sourcing strategies, seeking to diversify production footprints and establish strategic partnerships with domestic contract development organizations to mitigate exposure to tariff fluctuations.

In parallel, distributors and healthcare providers are negotiating revised pricing arrangements to balance reimbursement pressures with the imperative of maintaining patient access to advanced therapies. Despite near-term cost headwinds, innovative financing frameworks-such as outcome-based contracts and volume-risk agreements-are emerging as mechanisms to distribute tariff impacts across stakeholders. Looking ahead, organizations that proactively optimize their procurement and logistics operations will be better positioned to sustain supply chain resilience and protect margins in an environment marked by trade policy uncertainty.

Deep Dive into Comprehensive Segmentation Insights Illuminating Diverse Therapy Types, Administration Routes, Distribution Channels, and End User Profiles

The study categorizes chronic joint pain therapies across multiple dimensions to capture the full spectrum of patient and stakeholder needs. In terms of therapy type, it distinguishes between alternative approaches-such as acupuncture, chiropractic care, and herbal remedies-device-based interventions including cryotherapy platforms, laser and ultrasound systems, neuromodulation stimulators, and emerging wearable solutions. Digital modalities span mobile health applications, telemedicine services, and immersive virtual reality platforms designed to enhance rehabilitation adherence. Pharmaceutical regimens encompass corticosteroids, nonsteroidal anti-inflammatories differentiated by COX-1 and COX-2 selectivity, opioid management protocols, and disease-modifying antirheumatic drugs with specialized biologic subclasses targeting IL-6, JAK, and TNF pathways. Finally, physical therapy methods integrate exercise regimens, hydrotherapy sessions, and manual mobilization techniques to support functional recovery.

Beyond therapy categorization, the research examines administration routes-from injectable and intra-articular formulations to oral, topical, and transdermal applications-to elucidate patient preference and compliance patterns. It also differentiates product classifications into prescription and over-the-counter segments, while assessing distribution networks spanning hospital and specialty clinic pharmacies, as well as retail and online dispensaries. Analysis of end users reveals divergent requirements across hospital settings, outpatient clinics, and homecare environments. Pathology segmentation focuses on prevalent conditions such as gout, osteoarthritis, and rheumatoid arthritis. Mechanism-of-action breakdowns explore biologic interventions alongside hyaluronic acid injections, neuromodulator applications, and platelet-rich plasma therapies. Finally, technological enablers-including advanced drug delivery systems, cryotherapy devices, laser and tens units, ultrasound instruments, and next-generation wearables-are evaluated for their role in advancing patient outcomes.

Strategic Examination of Regional Dynamics Highlighting Growth Drivers and Barriers Across the Americas, Europe Middle East & Africa, and Asia-Pacific Markets

Regional dynamics exhibit distinct growth catalysts and obstacles across the Americas, Europe, Middle East & Africa, and Asia-Pacific territories. In the Americas, robust healthcare infrastructure, well-established reimbursement frameworks, and high prevalence of arthritis drive rapid adoption of both conventional and novel therapies. Market participants benefit from streamlined regulatory pathways, though pricing pressures and payer negotiations necessitate evidence generation that demonstrates real-world effectiveness and cost utility.

Across Europe, the Middle East & Africa, regulatory harmonization initiatives continue to facilitate cross-border market access, while pricing and reimbursement mechanisms exert downward pressure on product margins. However, the expansion of specialty clinics and growth in professional manual therapy services present opportunities for differentiated offerings. In Asia-Pacific, the convergence of aging demographics and increasing healthcare expenditure fuels an expanding patient pool. Telemedicine uptake and local manufacturing expansion are shaping competitive dynamics, as stakeholders prioritize affordability and accessibility in rapidly evolving healthcare ecosystems.

Insightful Profiles and Performance Highlights of Leading Organizations Shaping Innovation and Competitive Strategies in the Joint Pain Therapy Sector

Industry incumbents and emerging innovators are leveraging differentiated strategies to secure competitive advantage. Leading pharmaceutical corporations continue to invest heavily in biologic pipelines, focusing on next-generation TNF and JAK inhibitors with enhanced safety profiles. Simultaneously, medical device firms are advancing miniaturized cryotherapy systems and smart wearable platforms that integrate with digital health ecosystems. Partnerships between established device manufacturers and software developers are accelerating the commercialization of connected pain management solutions.

At the same time, specialized contract research and development organizations are playing an increasingly pivotal role by offering end-to-end services that encompass clinical trial management, regulatory dossier preparation, and post-market surveillance. This trend enables both large and mid-sized companies to optimize R&D efficiency while navigating complex compliance requirements. Across the competitive landscape, M&A activity has focused on acquiring niche digital therapy specialists and regenerative medicine startups, underscoring a broader shift toward holistic, multi-modal pain management strategies.

Strategic Actionable Recommendations for Industry Leaders to Navigate Market Challenges and Leverage Emerging Opportunities in Joint Pain Therapy

To thrive in an increasingly sophisticated joint pain therapy environment, industry leaders should prioritize integrated digital and device-based platforms that enable real-time patient monitoring and personalized treatment adjustments. Strategic investment in advanced analytics and patient-reported outcome data will be essential for substantiating value propositions during payer negotiations. Moreover, diversifying supply chain sources-particularly through localized manufacturing partnerships-can mitigate exposure to trade policy volatility and ensure continuity of critical component availability.

Additionally, forging collaborative alliances with academic centers and condition-specific advocacy groups can foster co-development of protocols that address unmet patient needs. Organizations are advised to engage proactively with regulatory agencies to shape policy frameworks that support innovative modalities. Finally, adopting outcome-based contracting models will align incentives across stakeholders, streamline reimbursement pathways, and deliver measurable improvements in patient functionality and satisfaction.

Rigorous Research Methodology Detailing Data Collection Techniques, Analytical Frameworks, and Validation Processes Underpinning the Joint Pain Therapy Study

This research is grounded in a rigorous methodology that combines qualitative and quantitative approaches. Primary data was collected through in-depth interviews with opinion leaders, clinicians, and key decision-makers across the chronic pain therapy spectrum. These insights were augmented by extensive desk research, including peer-reviewed journals, clinical trial registries, and regulatory filings to ensure comprehensive contextual understanding.

Quantitative analysis incorporated data triangulation techniques, synthesizing multiple data sources to validate therapeutic adoption trends and technology utilization rates. The analytical framework was designed to assess market drivers, barriers, and competitive dynamics through structured scoring models. Finally, findings were subject to external expert validation to enhance accuracy and reliability, ensuring that strategic recommendations reflect the latest industry developments and stakeholder perspectives.

Comprehensive Conclusion Synthesizing Key Insights and Strategic Implications for Stakeholders in the Evolving Joint Pain Therapy Landscape

In closing, the chronic joint pain therapy landscape is undergoing a period of rapid transformation, driven by technological innovation, evolving reimbursement models, and shifting patient expectations. Stakeholders that harness integrated digital-device solutions and invest in biologic and regenerative pipelines will be well-positioned to meet the complex demands of this dynamic environment. Collaborative partnerships and outcome-focused contracting models are emerging as key differentiators in an increasingly competitive space.

As the industry continues to embrace multidisciplinary care pathways and real-world evidence generation, organizations must remain agile, informed, and patient-centric. By aligning strategic initiatives with regulatory trends and patient outcome goals, stakeholders can accelerate adoption of breakthrough therapies and deliver meaningful improvements in quality of life. This synthesis of insights underscores the critical imperative for sustained innovation and cross-sector collaboration.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Therapy Type
    • Alternative Therapy
      • Acupuncture
      • Chiropractic
      • Herbal Remedies
    • Device Therapy
      • Cryotherapy Devices
      • Laser Therapy Devices
      • Transcutaneous Electrical Nerve Stimulation Devices
      • Ultrasound Therapy Devices
      • Wearable Devices
    • Digital Therapy
      • Mobile Applications
      • Telemedicine
      • Virtual Reality Therapy
    • Drug Therapy
      • Corticosteroids
      • Disease Modifying Anti Rheumatic Drugs
        • Biologics
          • Il 6 Inhibitors
          • Jak Inhibitors
          • Tnf Inhibitors
        • Hydroxychloroquine
        • Methotrexate
        • Sulfasalazine
      • Nsaids
        • Cox 1 Inhibitors
        • Cox 2 Inhibitors
      • Opioids
    • Physical Therapy
      • Exercise Therapy
      • Hydrotherapy
      • Manual Therapy
  • Administration Route
    • Injectable
    • Intra Articular
    • Oral
    • Topical
    • Transdermal
  • Product Type
    • Over The Counter
    • Prescription
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
    • Specialty Clinics
  • End User
    • Clinics
    • Homecare Settings
    • Hospitals
  • Pathology
    • Gout
    • Osteoarthritis
    • Rheumatoid Arthritis
  • Mechanism Of Action
    • Biologics
      • Il 6 Inhibitors
      • Jak Inhibitors
      • Tnf Inhibitors
    • Cox Inhibitors
      • Cox 1
      • Cox 2
    • Hyaluronic Acid Injections
    • Neuromodulators
      • Capsaicin
      • Lidocaine
    • Platelet Rich Plasma
  • Technology
    • Cryotherapy Devices
    • Drug Delivery Systems
    • Laser Therapy Devices
    • Tens Devices
    • Ultrasound Therapy Devices
    • Wearable Devices
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • AbbVie Inc.
  • Johnson & Johnson
  • Roche Holding AG
  • Pfizer Inc.
  • Amgen Inc.
  • Novartis AG
  • Sanofi S.A.
  • Zimmer Biomet Holdings, Inc.
  • Stryker Corporation
  • Smith & Nephew plc

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rise of personalized biologic injections targeting joint inflammation pathways
5.2. Expansion of digital remote patient monitoring systems for chronic joint pain
5.3. Integration of AI-driven predictive analytics to customize pain management regimens
5.4. Development of sustained-release hydrogel implants for localized joint therapy
5.5. Adoption of telehealth platforms for multidisciplinary chronic pain care coordination
5.6. Growth of non-opioid neuromodulation devices for long-term joint pain relief
5.7. Advancements in gene editing techniques to address underlying arthritis pathophysiology
5.8. Emergence of mobile app-based cognitive behavioral therapy for joint pain self-management
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Chronic Pain Therapy Solutions for Joints Market, by Therapy Type
8.1. Introduction
8.2. Alternative Therapy
8.2.1. Acupuncture
8.2.2. Chiropractic
8.2.3. Herbal Remedies
8.3. Device Therapy
8.3.1. Cryotherapy Devices
8.3.2. Laser Therapy Devices
8.3.3. Transcutaneous Electrical Nerve Stimulation Devices
8.3.4. Ultrasound Therapy Devices
8.3.5. Wearable Devices
8.4. Digital Therapy
8.4.1. Mobile Applications
8.4.2. Telemedicine
8.4.3. Virtual Reality Therapy
8.5. Drug Therapy
8.5.1. Corticosteroids
8.5.2. Disease Modifying Anti Rheumatic Drugs
8.5.2.1. Biologics
8.5.2.1.1. Il 6 Inhibitors
8.5.2.1.2. Jak Inhibitors
8.5.2.1.3. Tnf Inhibitors
8.5.2.2. Hydroxychloroquine
8.5.2.3. Methotrexate
8.5.2.4. Sulfasalazine
8.5.3. Nsaids
8.5.3.1. Cox 1 Inhibitors
8.5.3.2. Cox 2 Inhibitors
8.5.4. Opioids
8.6. Physical Therapy
8.6.1. Exercise Therapy
8.6.2. Hydrotherapy
8.6.3. Manual Therapy
9. Chronic Pain Therapy Solutions for Joints Market, by Administration Route
9.1. Introduction
9.2. Injectable
9.3. Intra Articular
9.4. Oral
9.5. Topical
9.6. Transdermal
10. Chronic Pain Therapy Solutions for Joints Market, by Product Type
10.1. Introduction
10.2. Over The Counter
10.3. Prescription
11. Chronic Pain Therapy Solutions for Joints Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
11.5. Specialty Clinics
12. Chronic Pain Therapy Solutions for Joints Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Homecare Settings
12.4. Hospitals
13. Chronic Pain Therapy Solutions for Joints Market, by Pathology
13.1. Introduction
13.2. Gout
13.3. Osteoarthritis
13.4. Rheumatoid Arthritis
14. Chronic Pain Therapy Solutions for Joints Market, by Mechanism Of Action
14.1. Introduction
14.2. Biologics
14.2.1. Il 6 Inhibitors
14.2.2. Jak Inhibitors
14.2.3. Tnf Inhibitors
14.3. Cox Inhibitors
14.3.1. Cox 1
14.3.2. Cox 2
14.4. Hyaluronic Acid Injections
14.5. Neuromodulators
14.5.1. Capsaicin
14.5.2. Lidocaine
14.6. Platelet Rich Plasma
15. Chronic Pain Therapy Solutions for Joints Market, by Technology
15.1. Introduction
15.2. Cryotherapy Devices
15.3. Drug Delivery Systems
15.4. Laser Therapy Devices
15.5. Tens Devices
15.6. Ultrasound Therapy Devices
15.7. Wearable Devices
16. Americas Chronic Pain Therapy Solutions for Joints Market
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. Argentina
17. Europe, Middle East & Africa Chronic Pain Therapy Solutions for Joints Market
17.1. Introduction
17.2. United Kingdom
17.3. Germany
17.4. France
17.5. Russia
17.6. Italy
17.7. Spain
17.8. United Arab Emirates
17.9. Saudi Arabia
17.10. South Africa
17.11. Denmark
17.12. Netherlands
17.13. Qatar
17.14. Finland
17.15. Sweden
17.16. Nigeria
17.17. Egypt
17.18. Turkey
17.19. Israel
17.20. Norway
17.21. Poland
17.22. Switzerland
18. Asia-Pacific Chronic Pain Therapy Solutions for Joints Market
18.1. Introduction
18.2. China
18.3. India
18.4. Japan
18.5. Australia
18.6. South Korea
18.7. Indonesia
18.8. Thailand
18.9. Philippines
18.10. Malaysia
18.11. Singapore
18.12. Vietnam
18.13. Taiwan
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. AbbVie Inc.
19.3.2. Johnson & Johnson
19.3.3. Roche Holding AG
19.3.4. Pfizer Inc.
19.3.5. Amgen Inc.
19.3.6. Novartis AG
19.3.7. Sanofi S.A.
19.3.8. Zimmer Biomet Holdings, Inc.
19.3.9. Stryker Corporation
19.3.10. Smith & Nephew plc
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PATHOLOGY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PATHOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 20. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 31. CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET: RESEARCHAI
FIGURE 32. CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET: RESEARCHSTATISTICS
FIGURE 33. CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET: RESEARCHCONTACTS
FIGURE 34. CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ALTERNATIVE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ALTERNATIVE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ACUPUNCTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ACUPUNCTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY CHIROPRACTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY CHIROPRACTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY HERBAL REMEDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY HERBAL REMEDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ALTERNATIVE THERAPY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DEVICE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DEVICE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY CRYOTHERAPY DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY CRYOTHERAPY DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY LASER THERAPY DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY LASER THERAPY DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ULTRASOUND THERAPY DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ULTRASOUND THERAPY DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DEVICE THERAPY, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DEVICE THERAPY, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DIGITAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DIGITAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY MOBILE APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY MOBILE APPLICATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY TELEMEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY TELEMEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY VIRTUAL REALITY THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY VIRTUAL REALITY THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DIGITAL THERAPY, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DIGITAL THERAPY, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DRUG THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DRUG THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DISEASE MODIFYING ANTI RHEUMATIC DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DISEASE MODIFYING ANTI RHEUMATIC DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY IL 6 INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY IL 6 INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY JAK INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY JAK INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY TNF INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY TNF INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY HYDROXYCHLOROQUINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY HYDROXYCHLOROQUINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY METHOTREXATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY METHOTREXATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY SULFASALAZINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY SULFASALAZINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DISEASE MODIFYING ANTI RHEUMATIC DRUGS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DISEASE MODIFYING ANTI RHEUMATIC DRUGS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY NSAIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY NSAIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COX 1 INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COX 1 INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COX 2 INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COX 2 INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY NSAIDS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY NSAIDS, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY OPIOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DRUG THERAPY, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DRUG THERAPY, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY EXERCISE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY EXERCISE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY HYDROTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY HYDROTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY MANUAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY MANUAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY INTRA ARTICULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY INTRA ARTICULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY GOUT, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY GOUT, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY IL 6 INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY IL 6 INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY JAK INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY JAK INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY TNF INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY TNF INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COX INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COX INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COX 1, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COX 1, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COX 2, BY REGION, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COX 2, BY REGION, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COX INHIBITORS, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COX INHIBITORS, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY HYALURONIC ACID INJECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY HYALURONIC ACID INJECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY NEUROMODULATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY NEUROMODULATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY CAPSAICIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY CAPSAICIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY LIDOCAINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY LIDOCAINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY NEUROMODULATORS, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY NEUROMODULATORS, 2025-2030 (USD MILLION)
TABLE 165. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PLATELET RICH PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 166. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PLATELET RICH PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 167. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 168. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 169. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY CRYOTHERAPY DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 170. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY CRYOTHERAPY DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 171. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 172. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 173. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY LASER THERAPY DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 174. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY LASER THERAPY DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 175. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY TENS DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 176. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY TENS DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 177. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ULTRASOUND THERAPY DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 178. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ULTRASOUND THERAPY DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 179. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 180. GLOBAL CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ALTERNATIVE THERAPY, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DEVICE THERAPY, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DEVICE THERAPY, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DIGITAL THERAPY, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DIGITAL THERAPY, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DRUG THERAPY, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DRUG THERAPY, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DISEASE MODIFYING ANTI RHEUMATIC DRUGS, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DISEASE MODIFYING ANTI RHEUMATIC DRUGS, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY NSAIDS, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY NSAIDS, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 208. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 209. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 210. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 211. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 212. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 213. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COX INHIBITORS, 2018-2024 (USD MILLION)
TABLE 214. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COX INHIBITORS, 2025-2030 (USD MILLION)
TABLE 215. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY NEUROMODULATORS, 2018-2024 (USD MILLION)
TABLE 216. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY NEUROMODULATORS, 2025-2030 (USD MILLION)
TABLE 217. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 218. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 219. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 220. AMERICAS CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ALTERNATIVE THERAPY, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DEVICE THERAPY, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DEVICE THERAPY, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DIGITAL THERAPY, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DIGITAL THERAPY, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DRUG THERAPY, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DRUG THERAPY, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DISEASE MODIFYING ANTI RHEUMATIC DRUGS, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DISEASE MODIFYING ANTI RHEUMATIC DRUGS, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY NSAIDS, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY NSAIDS, 2025-2030 (USD MILLION)
TABLE 237. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 238. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 239. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 240. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 241. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 248. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 249. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 250. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 251. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 252. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 253. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COX INHIBITORS, 2018-2024 (USD MILLION)
TABLE 254. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY COX INHIBITORS, 2025-2030 (USD MILLION)
TABLE 255. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY NEUROMODULATORS, 2018-2024 (USD MILLION)
TABLE 256. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY NEUROMODULATORS, 2025-2030 (USD MILLION)
TABLE 257. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 258. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 259. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 260. UNITED STATES CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 261. CANADA CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 262. CANADA CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 263. CANADA CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ALTERNATIVE THERAPY, 2018-2024 (USD MILLION)
TABLE 264. CANADA CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY ALTERNATIVE THERAPY, 2025-2030 (USD MILLION)
TABLE 265. CANADA CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DEVICE THERAPY, 2018-2024 (USD MILLION)
TABLE 266. CANADA CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DEVICE THERAPY, 2025-2030 (USD MILLION)
TABLE 267. CANADA CHRONIC PAIN THERAPY SOLUTIONS FOR JOINTS MARKET SIZE, BY DIGITAL THERAPY, 2018-2024 (USD MILLION)
TABLE 268. CANADA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Chronic Pain Therapy Solutions for Joints market report include:
  • AbbVie Inc.
  • Johnson & Johnson
  • Roche Holding AG
  • Pfizer Inc.
  • Amgen Inc.
  • Novartis AG
  • Sanofi S.A.
  • Zimmer Biomet Holdings, Inc.
  • Stryker Corporation
  • Smith & Nephew plc

Related Topics

Related Reports

Cold Pain Therapy Market by Type (Cold Packs, Cold Sprays, Compression Cold Therapy), End User (Home Care Settings, Hospitals & Clinics, Rehabilitation Centers), Application - Global Forecast 2025-2030 - Product Image

Cold Pain Therapy Market by Type (Cold Packs, Cold Sprays, Compression Cold Therapy), End User (Home Care Settings, Hospitals & Clinics, Rehabilitation Centers), Application - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Pain Management Therapeutics Market by Drug Class (Adjuvant Analgesics, Local Anesthetics, Neuropathic Pain Agents), Route Of Administration (Oral, Parenteral, Topical), Indication, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Pain Management Therapeutics Market by Drug Class (Adjuvant Analgesics, Local Anesthetics, Neuropathic Pain Agents), Route Of Administration (Oral, Parenteral, Topical), Indication, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Chronic Post-Amputation Pain Management Market by Treatment Type (Non-Pharmacological, Pharmacological, Surgical), Drug Class (Anti-Epileptics, Antidepressants, Local Anesthetics), End User, Route Of Administration, Pain Type - Global Forecast 2025-2030 - Product Image

Chronic Post-Amputation Pain Management Market by Treatment Type (Non-Pharmacological, Pharmacological, Surgical), Drug Class (Anti-Epileptics, Antidepressants, Local Anesthetics), End User, Route Of Administration, Pain Type - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Cold Pain Therapy - Global Strategic Business Report - Product Image

Cold Pain Therapy - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
US Non-postoperative Acute Pain - Market Insights, Epidemiology, and Market Forecast - 2032 - Product Image

US Non-postoperative Acute Pain - Market Insights, Epidemiology, and Market Forecast - 2032

  • Report
  • 129 Pages
  • United States
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.